| Cat. No. |
Product Name |
Information |
| PC-38864 |
Pavurutamab
BCMA/CD3 BiTE antibody
|
Pavurutamab (AMG 701) is a half-life extended anti-BCMA BiTE (bispecific T-cell engager) recombinant antibody, induces selective cytotoxicity against BCMA-expressing MM cells (EC50=18.8 pM), T-cell activation, and cytokine release in vitro and in vivo. |
| PC-38863 |
Pacanalotamab
BCMA/CD3 BiTE antibody
|
Pacanalotamab (AMG420) is a bispecific T-cell engager (BiTE) antibody, binds BCMA (B-Cell Maturation Antigen) on MM cells and CD3 on T cells. |
| PC-38862 |
Omodenbamab
Anti-SpA mAb
|
Omodenbamab is an anti-SpA (Staphylococcal protein A) humanized monoclonal antibody. Isotype: IgG3-kappa. Anti-[Staphylococcus aureus SpA (Staphylococcal protein A)], human monoclonal antibody. |
| PC-38859 |
Dafsolimab
Anti-CD3E mAb
|
Dafsolimab is a recombinant anti-CD3E (CD3 epsilon) monoclonal antibody.
Isotype: IgG2B-kappa. |
| PC-38858 |
Coprelotamab
Anti-ERBB2 mAb
|
Coprelotamab (GB221) is a recombinant anti-HER2 (ERBB2) humanized monoclonal antibody for metastatic breast cancer treatment. |
| PC-38857 |
Bentracimab
Anti-ticagrelor mAb
|
Bentracimab (PB2452) is a neutralizing monoclonal antibody fragment that binds the antiplatelet drug ticagrelor with high affinity, a ticagrelor reversal agent. |
| PC-38855 |
Barecetamab
Anti-ErbB3 mAb
|
Barecetamab (ISU 104) is a highly potent, fully human anti-ErbB3 monoclonal antibody, binds potently and specifically to the NRG1 binding region of domain 3 of ErbB3, exhibits potent antitumorigenic activity. |
| PC-38854 |
Bapotulimab
Anti-ILDR2 mAb
|
Bapotulimab (BAY 1905254) is a human/mouse/monkey cross-reactive antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2), blocks the immunosuppressive activity of ILDR2 for cancer immunotherapy. |
| PC-38853 |
Apitegromab
Anti-promyostatin mAb
|
Apitegromab (SRK-015) is a fully human anti-proMyostatin monoclonal antibody (mAb) of the immunoglobulin G4 (IgG4)/lambda isotype that specifically binds to human pro/latent myostatin with high affinity inhibiting myostatin activation. |
| PC-38852 |
Teclistamab
Anti-BCMA/CD3
|
Teclistamab (JNJ-64007957) is a BCMAxCD3 bispecific antibody, recruits and activates T cells to kill BCMA-expressing MM cells. |
| PC-38851 |
Alnuctamab
Anti-BCMA/CD3
|
Alnuctamab (CC-93269) is a T-cell redirecting bispecific antibody (BiTE) targeting BCMA for the treatment of multiple myeloma. |
| PC-38834 |
Ociperlimab
Anti-TIGIT mAb
|
Ociperlimab (BGB-A1217) is a novel humanized IgG1 anti-TIGIT antibody (mAb) with anti-tumor activities. |
